Thrombotic Microangiopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA guidance · 2026-07-15
EMA Opinion under re-examination: Yartemlea (narsoplimab) — Omeros Ireland Limited
EMA opinion under re-examination for Yartemlea (narsoplimab) by Omeros Ireland Limited in therapeutic areas including Thrombotic Microangiop…